Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Mitoredox shifts in mitochondrial dysfunction.
Journal: Free radical biology & medicine
Published: March 31, 2026
Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findings.
Journal: Expert opinion on investigational drugs
Published: February 26, 2026
Safe and durable immune responses to a single dose DNA COVID-19 vaccine in previously vaccinated or SARS-CoV-2-infected adults: A phase 1 study.
Journal: Vaccine
Published: November 27, 2025
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Journal: Gynecologic oncology
Published: November 07, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: April 08, 2025
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: November 28, 2024
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study.
Journal: The Lancet. Haematology
Published: March 15, 2024
A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?
Journal: Leukemia research
Published: November 07, 2023
Epilepsy: Mitochondrial connections to the 'Sacred' disease.
Journal: Mitochondrion
Published: June 01, 2023
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.
Journal: Gynecologic oncology
Published: May 09, 2023
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice.
Journal: American journal of hematology
Published: October 26, 2022
Last Updated: 09/26/2026